UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
     Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934


Date of Report (Date of earliest event reported): June 21, 2007
                                                 -------------------------------

                              POSSIS MEDICAL, INC.
- --------------------------------------------------------------------------------
             (Exact name of registrant as specified in its charter)

         Minnesota                      0-944                    41-0783184
- --------------------------------------------------------------------------------
(State or other jurisdiction    (Commission File Number)        (IRS Employer
     of incorporation)                                       Identification No.)

9055 Evergreen Boulevard NW, Minneapolis, MN                      55433-8003
- --------------------------------------------------------------------------------
(Address of principal executive offices)                          (Zip Code)

Registrant's telephone number, including area code  763-780-4555
                                                   -----------------------------

                                 Not Applicable
- --------------------------------------------------------------------------------
         (Former name or former address, if changed since last report.)


Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):

[ ] Written communications pursuant to Rule 425 under the Securities Act (17
    CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
    CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
    Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
    Exchange Act (17 CFR 240.13e-4(c))




Item 7.01 - Regulation FD Disclosure

On June 21, 2007, Possis Medical, Inc., announced that it is participating in
the Jefferies Healthcare Conference in New York City on Thursday, June 28, 2007.
Robert Dutcher, president and CEO, is scheduled to present a company overview
and discuss Possis' pioneering medical technologies to conference attendees at
9:40 a.m. ET.

Item 9.01 Financial Statements and Exhibits

[c] Exhibits

99.1 Press Release, dated June 21, 2007, issued by Possis Medical, Inc.



                                   SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

Possis Medical, Inc.
- --------------------
(Registrant)

Date: June 21, 2007
      -------------

By: /s/ Jules L. Fisher
    ---------------------------------------------------
    Jules L. Fisher
    Vice President, Finance and Chief Financial Officer




                                  EXHIBIT INDEX

Exhibit No.   Description
- -----------   -----------

99.1          Press Release, dated June 21, 2007, issued by Possis Medical, Inc.